Sichuan Guowei Pharmaceutical

Sichuan Guowei Pharmaceutical is a China-based pharmaceutical company that focuses on the research, development, and large-scale manufacturing of high-end generic and innovative drugs. The company is particularly recognized for its leadership in the Omega-3 fatty acid market, having been the first in China to receive approval for 90% high-purity Omega-3-acid ethyl esters. Its diverse product portfolio covers major therapeutic areas including cardiovascular health, anti-infectives, clinical nutrition, and gastroenterology. Sichuan Guowei operates sophisticated manufacturing facilities in Chengdu that adhere to international GMP standards, enabling them to supply both domestic and global markets. The company integrates R&D, production, and sales to maintain a competitive position in the complex drug formulation sector.